Constitutive Activation of the NEAT1/miR-22-3p/Ltb4r1 Signaling Pathway in Mice with Myocardial Injury Following Acute Myocardial Infarction
Overview
Authors
Affiliations
Coronary heart disease (CHD) with myocardial infarction (MI) being the manifestation of its advanced manifestation, remains the primary cause of mortality and disability worldwide. Aberrant expression of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) can affect the occurrence of MI in CHD. The present study aimed to explore whether NEAT1 sponging with miR-22-3p affected MI in CHD and its related mechanism. We established that the NEAT1 and Ltb4r1 expressions were increased, while miR-22-3p expression was down-regulated in MI mice following CHD. NEAT1 could competitively bind to miR-22-3p and positively regulate Ltb4r1 expression. Ltb4r1 was the downstream target of miR-22-3p. Moreover, silencing NEAT1 or downregulating Ltb4rl expression resulted in improved cardiac function, reduced infarct size, and declined levels of IL-1β, IL-6, and IL-18. Furthermore, silencing of NEAT1 also inhibited apoptosis by decreasing levels of Cleaved caspase-3 and Bax, and increasing Bcl-2 level through sponging miR-22-3p, resulting in reduced myocardial injury in CHD. Altogether, the activation of the NEAT1/miR-22-3p/Ltb4r1 signaling pathway appears to aggravate myocardial injury following a MI, which suggested that this signaling may be a useful target for improved and more individualized treatments for MI.
Yin C, Ge Z, Yuan J, Chen Y, Tang Y, Xiang Y Am J Physiol Cell Physiol. 2024; 326(6):C1721-C1734.
PMID: 38646788 PMC: 11371316. DOI: 10.1152/ajpcell.00587.2023.
The roles of long noncoding RNA NEAT1 in cardiovascular diseases.
Jiang X, Zhang M Hypertens Res. 2024; 47(3):735-746.
PMID: 38177287 DOI: 10.1038/s41440-023-01551-0.
Zhang M, Chen J, Wang Y, Kang G, Zhang Y, Han X Drug Des Devel Ther. 2022; 16:3117-3132.
PMID: 36132334 PMC: 9484776. DOI: 10.2147/DDDT.S370473.
LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway.
Ding Y, Ge Y, Wang D, Liu Q, Sun S, Hua L Mol Cells. 2022; 45(6):388-402.
PMID: 35680373 PMC: 9200663. DOI: 10.14348/molcells.2022.2232.
Wu C, Liu B, Wang R, Li G Front Cardiovasc Med. 2022; 8:809580.
PMID: 35111829 PMC: 8801508. DOI: 10.3389/fcvm.2021.809580.